Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Grunnet

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Neuroscience Letters|October 9, 2017
The sodium channel activator Lu AE98134 normalizes the altered firing properties of fast spiking interneurons in Dlx5/6<sup>+/-</sup> miceNadia Lybøl von Schoubye, Kristen Frederiksen, Uffe Kristiansen, et al.
Heart Rhythm|December 28, 2014
Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horsesMaria Mathilde Haugaard, Eva Zander Hesselkilde, Steen Pehrson, et al.
British Journal of Pharmacology|May 27, 2017
Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in ratsMorten Laursen, Lilliana Beck, Jan Kehler, et al.
Frontiers in Pharmacology|June 2, 2020
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in ManBo Hjorth Bentzen, Sofia Hammami Bomholtz, Rafel Simó-Vicens, et al.
Nature Medicine|December 13, 2023
Inhibition of the K<sub>Ca</sub>2 potassium channel in atrial fibrillation: a randomized phase 2 trialAnders G Holst, János Tomcsányi, Birgitte Vestbjerg, et al.
Cardiovascular Research|October 24, 2013
G-protein-coupled inward rectifier potassium current contributes to ventricular repolarizationBo Liang, Jakob D Nissen, Morten Laursen, et al.
Clinical and Translational Science|July 30, 2020
First Clinical Study with AP30663 - a K<sub>Ca</sub> 2 Channel Inhibitor in Development for Conversion of Atrial FibrillationPim Gal, Erica S Klaassen, Kirsten R Bergmann, et al.
European Journal of Pharmacology|April 9, 2013
Characterization of a novel high-potency positive modulator of K(v)7 channelsWilliam Dalby-Brown, Carsten Jessen, Charlotte Hougaard, et al.
Frontiers in Pharmacology|July 6, 2019
The K<sub>Ca</sub>2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig HeartsJeppe Egedal Kirchhoff, Mark Alexander Skarsfeldt, Kalai Mangai Muthukumarasamy, et al.
European Journal of Pharmacology|August 4, 2020
In vitro and in vivo characterization of Lu AA41178: A novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disordersMorten Grupe, Bo Hjorth Bentzen, Tau Benned-Jensen, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Neuroscience Letters|October 9, 2017
The sodium channel activator Lu AE98134 normalizes the altered firing properties of fast spiking interneurons in Dlx5/6<sup>+/-</sup> miceNadia Lybøl von Schoubye, Kristen Frederiksen, Uffe Kristiansen, et al.
Heart Rhythm|December 28, 2014
Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horsesMaria Mathilde Haugaard, Eva Zander Hesselkilde, Steen Pehrson, et al.
British Journal of Pharmacology|May 27, 2017
Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in ratsMorten Laursen, Lilliana Beck, Jan Kehler, et al.
Frontiers in Pharmacology|June 2, 2020
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in ManBo Hjorth Bentzen, Sofia Hammami Bomholtz, Rafel Simó-Vicens, et al.
Nature Medicine|December 13, 2023
Inhibition of the K<sub>Ca</sub>2 potassium channel in atrial fibrillation: a randomized phase 2 trialAnders G Holst, János Tomcsányi, Birgitte Vestbjerg, et al.
Cardiovascular Research|October 24, 2013
G-protein-coupled inward rectifier potassium current contributes to ventricular repolarizationBo Liang, Jakob D Nissen, Morten Laursen, et al.
Clinical and Translational Science|July 30, 2020
First Clinical Study with AP30663 - a K<sub>Ca</sub> 2 Channel Inhibitor in Development for Conversion of Atrial FibrillationPim Gal, Erica S Klaassen, Kirsten R Bergmann, et al.
European Journal of Pharmacology|April 9, 2013
Characterization of a novel high-potency positive modulator of K(v)7 channelsWilliam Dalby-Brown, Carsten Jessen, Charlotte Hougaard, et al.
Frontiers in Pharmacology|July 6, 2019
The K<sub>Ca</sub>2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig HeartsJeppe Egedal Kirchhoff, Mark Alexander Skarsfeldt, Kalai Mangai Muthukumarasamy, et al.
European Journal of Pharmacology|August 4, 2020
In vitro and in vivo characterization of Lu AA41178: A novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disordersMorten Grupe, Bo Hjorth Bentzen, Tau Benned-Jensen, et al.
Pageof 14